$Ramsay Health Care Ltd (RHC.AU)$杰富瑞给了拉姆齐买入建议,目标股价为65.40澳元/股。 在KKR联合财团选择不改进其先前提出的收购拉姆齐医疗保健方案后,杰富瑞认为澳大利亚私立医院运营商恢复了业务正常。分析师大卫·斯坦顿在一份备忘录中表示,拉姆齐的澳大利亚业务将再次受到新冠疫情影响,导致1H Ebit受损。 “不过,斯坦顿表示,拉姆齐在较长期内将更为强劲。然而,短期内,人员短缺将持续,这意味着拉姆齐可能无法吸纳增加的成交量。”
$Actinogen Medical Ltd (ACW.AU)$: Actinogen gets a speculative buy rating and A$0.09 target price as Bell Potter initiates coverage of the stock. Australian biotech company following promising initial trial results for its lead cognitive-impairment drug candidate. Actinogen's Xanamem inhibits the enzyme that activates cortisol, high levels of which have been linked to diseases including Alzheimer's and major depression. $TPG Telecom Ltd (TPG.AU)$: UBS trim...
103677010 : 注意到